UBS Group Analysts Give Lanxess (ETR:LXS) a €53.00 Price Target
UBS Group set a €53.00 ($61.63) target price on Lanxess (ETR:LXS) in a research report report published on Tuesday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.
LXS has been the topic of a number of other reports. DZ Bank reaffirmed a neutral rating on shares of Lanxess in a report on Tuesday, August 6th. Nord/LB set a €53.00 ($61.63) target price on Lanxess and gave the stock a neutral rating in a report on Friday, August 2nd. Barclays set a €55.00 ($63.95) target price on Lanxess and gave the stock a neutral rating in a report on Thursday, August 8th. Deutsche Bank set a €70.00 ($81.40) target price on Lanxess and gave the stock a buy rating in a report on Monday, August 5th. Finally, JPMorgan Chase & Co. set a €60.00 ($69.77) price target on Lanxess and gave the company a buy rating in a research report on Friday, August 2nd. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and eight have assigned a buy rating to the stock. Lanxess currently has a consensus rating of Hold and a consensus price target of €60.92 ($70.84).
ETR:LXS opened at €50.14 ($58.30) on Tuesday. The business’s 50-day moving average price is €53.46 and its 200 day moving average price is €50.06. The firm has a market cap of $4.55 billion and a P/E ratio of 11.53. Lanxess has a 52-week low of €39.47 ($45.90) and a 52-week high of €70.66 ($82.16). The company has a quick ratio of 1.51, a current ratio of 2.72 and a debt-to-equity ratio of 107.55.
LANXESS Aktiengesellschaft, a specialty chemicals company, develops, manufactures, and markets chemical intermediates, specialty chemicals, and plastics worldwide. It operates in five segments: Advanced Intermediates, Specialty Additives, Performance Chemicals, Engineering Materials, and ARLANXEO. The Advanced Intermediates segment offers high-grade intermediates for the agrochemical and coating industries; fine chemicals as precursors and intermediates for the pharmaceutical, agrochemical, and specialty chemical industries; customer-specific specialties; organometallics; and tire chemicals.
See Also: Reverse Stock Split
Receive News & Ratings for Lanxess Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lanxess and related companies with MarketBeat.com's FREE daily email newsletter.